TARGET ONCOL - Targeted Oncology
Publications
- 2016
A Review of Clinical Studies and Practical Guide for the Administration of Triplet Chemotherapy Regimens with Bevacizumab in First-line Metastatic Colorectal Cancer
Loupakis, F., Stein, A., Ychou, M., Hermann, F., Salud, A. & Österlund, P., 06.2016, In: TARGET ONCOL. 11, 3, p. 293-308Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Histone Deacetylase Inhibitors Resensitize EGFR/EGFRvIII-Overexpressing, Erlotinib-Resistant Glioblastoma Cells to Tyrosine Kinase Inhibition
Liffers, K., Kolbe, K., Westphal, M., Lamszus, K. & Schulte, A., 01.02.2016, In: TARGET ONCOL. 11, 1, p. 29-40Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2014
EGFR intron-1 CA repeat polymorphism is a predictor of relapse and survival in complete resected only surgically treated esophageal cancer
Vashist, Y. K., Trump, F., Gebauer, F., Kutup, A., Güngör, C., Kalinin, V., Muddasar, R., Vettorazzi, E., Yekebas, E. F., Brandt, B., Pantel, K. & Izbicki, J. R., 01.03.2014, In: TARGET ONCOL. 9, 1, p. 43-52 10 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2010
Glioma stem cells as a target for treatment.
Lamszus, K. & Günther, H., 2010, In: TARGET ONCOL. 5, 3, p. 211-215 3.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review